目的：观察脑卒中恢复期患者治疗中苓桂术甘汤加减治疗的效果。方法：回顾性选取2020年2月-2022年2月本院脑卒中恢复期患者60例，分为常规治疗基础上苓桂术甘汤加减治疗组（加减治疗组）、常规治疗组两组，各30例，统计分析两组中医症候积分、神经功能指标、神经功能缺损程度、平衡功能、运动功能、日常生活能力、临床疗效。结果：治疗后，两组患者中医症候积分、NSE水平均低于治疗前（P<0.05），BDNF、NGF水平均高于治疗前（P<0.05），加减治疗组患者的中医症候积分、NSE水平均低于常规治疗组（P<0.05），BDNF、NGF水平均高于常规治疗组（P<0.05）。治疗后，两组患者的NIHSS评分均低于治疗前（P<0.05），BBS评分、FMA评分、BI评分均高于治疗前（P<0.05），加减治疗组患者的NIHSS评分低于常规治疗组（P<0.05），BBS评分、FMA评分、BI评分均高于常规治疗组（P<0.05）。加减治疗组患者的总有效率93.33%（28/30）高于常规治疗组70.00%（21/30）（χ2=5.455，P<0.05）。结论：脑卒中恢复期患者治疗中苓桂术甘汤加减治疗的效果好。 Objective: To observe the effect of modified Lingguizhugan Decoction on stroke patients in recovery period.Methods:60 patients with cerebral apoplexy in our hospital from February 2020 to February 2022 were retrospectively analyzed. They were divided into two groups: the treatment group treated with modified or modified Lingguizhugan Decoction and the control group treated with modified or modified Lingguizhugan Decoction.Results: After treatment, the TCM symptom scores and NSE water of the two groups were lower than those before treatment (P <0.05), the BDNF and NGF water of the two groups were higher than those before treatment (P <0.05), the TCM symptom scores and NSE water of the two groups were lower than those of the conventional treatment group (P <0.05), the BDNF and NGF water of the two groups were higher than those of the conventional treatment group (P <0.05).After treatment, the NIHSS scores of the two groups were lower than those before treatment (P <0.05), and the BBS scores, FMA scores and BI scores were higher than those before treatment (P <0.05). The NIHSS scores of the modified treatment group were lower than those of the conventional treatment group (P <0.05), and the BBS scores, FMA scores and BI scores were higher than those of the conventional treatment group (P <0.05).The total effective rate in the modified and modified treatment group was 93.33%(28/30), higher than that in the conventional treatment group (70.00%(21/30))(χ2=5.455, P <0.05).Conclusion: The effect of modified Lingguizhugan Decoction on stroke patients in convalescent stage is good.
